Skip to main content

Can Wegovy or Ozempic be used for heart failure?

Medically reviewed by Melisa Puckey, BPharm. Last updated on Jan 22, 2025.

Can Wegovy or Ozempic (semaglutide) be used for heart failure?

Official answer

by Drugs.com

Yes, Wegovy and Ozempic active ingredient semaglutide has been used for heart failure to improve heart failure symptoms, increase exercise function, and weight loss, in a clinical trial called STEP-HFpE (NCT04788511). The clinical trial used Wegovy and Ozempic’s active ingredient, semaglutide, in patients with heart failure with preserved ejection fraction and obesity compared to placebo treatment, over 52 weeks.

The goal of treating heart failure is to slow disease progression (hospitalization and death) and to improve patients' quality of life including their symptoms and ability to move or exercise.

Benefits of Wegovy and Ozempic for heart failure patients with obesity

  • Improved heart failure symptoms, physical limitations, and quality of life (semaglutide +16.6, placebo +8.7) measured using KCCQ-CSS*
  • Increase in distance walked over 6 minutes (semaglutide +21.5 meters, placebo +1.2 meters)
  • Weight loss (-13% semaglutide, -2.6% placebo)

*The Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) assesses symptoms of heart failure, physical and social limitations, and overall quality of life. Scores range from 0 to 100, where higher scores indicate fewer symptoms and reduced physical limitations.

Wegovy and Ozempic (semaglutide) are currently not FDA approved for heart failure.

Heart failure with obesity

Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure where the heart maintains a normal or near-normal ejection fraction (LVEF is ≥50%). This type of heart failure is a condition that often occurs in individuals who have higher body weights. Patients with this type of heart failure and obesity have more clinical problems, greater symptoms, and impaired quality of life compared to patients with heart failure with preserved ejection fraction but no obesity.

By reducing body weight in obese HFpEF patients helps to reduce symptoms as HFpEF patients with lower body weight have less symptoms.

Related questions

How does Wegovy and Ozempic improve heart failure?

Wegovy and Ozempic improves heart failure with preserved ejection fraction (HFpEF) in obese patients by aiding weight loss. Semaglutide is a glucagon-like peptide 1 (GLP-1) agonist that works by mimicking a natural hormone in the body called GLP-1 which:

  • Helps control appetite and food intake
  • Stimulates insulin production from the pancreas
  • Reduces liver sugar production
  • Slows down digestion.

Summary

  • The active ingredient in Wegovy and Ozempic (semaglutide) has successfully been used to treat heart failure with preserved ejection fraction (HFpEF) in obese patients, in the clinical trial STEP-HFpE. Semaglutide improved heart failure symptoms, increased exercise function, and helped weight loss.
  • Wegovy and Ozempic are not currently FDA approved to treat heart failure with preserved ejection fraction (HFpEF) in obese patients.
References

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. Accessed January 22, 2025. https://www.nejm.org/doi/full/10.1056/NEJMoa2306963

Wegovy Package Insert FDA. Accessed January 22, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf

Ozempic Package Insert FDA. Accessed January 22, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209637s032lbl.pdf

National Library of Medicine Heart failure with preserved ejection fraction. Accessed January 22, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC6334030/#S0001

Read next

Why am I not losing weight on Ozempic?

Although Ozempic is not FDA-approved for weight loss, over 86% of people lose at least 5% of their body weight in trials that have studied semaglutide, the active ingredient of Ozempic. But the same clinical trials also show that just under 14% don’t lose weight, and some may even gain weight. Continue reading

How does semaglutide work for weight loss?

You could lose weight with semaglutide (Wegovy) because you will eat less, and feel fuller when you do eat. Semaglutide does this by closely mimicking a natural hormone in our bodies called incretin. It targets an area in the brain (called GLP-1 receptors) that help to regulate your appetite and how much you eat and works over the longer term. Continue reading

Where and how should Ozempic be injected?

Ozempic (generic name: semaglutide) is a pen prefilled with an injectable medicine given by self-injection once a week, on the same day each week, with or without meals. Ozempic is injected under the skin (subcutaneously) in your stomach (abdomen), thigh, or upper arm area. Continue reading

Related medical questions

Drug information

Related support groups